Integer Holdings shareholders voted overwhelmingly to approve a $5.7 billion acquisition by an affiliate of KKR-managed investment funds, clearing the final material hurdle for one of 2025's largest medical device take-privates. The vote count has not been disclosed, but the company confirmed approval without amendment or condition.
KKR is acquiring Integer at a moment when original equipment manufacturers in the cardiac, neuromodulation, and orthopedic device markets face simultaneous margin pressure from hospital purchasing consolidation and rising regulatory compliance costs. Integer supplies components and subassemblies to most major device makers—Medtronic, Abbott, Boston Scientific among them—and generated $1.52 billion in trailing twelve-month revenue as of the third quarter. The transaction values Integer at roughly 3.7x trailing sales, a multiple that reflects both the company's embedded position in multi-billion-dollar device platforms and the capital intensity of its clean-room manufacturing footprint.
The approval sets up a regulatory review timeline that will likely extend into the second quarter. Integer operates facilities subject to FDA Quality System Regulation and ISO 13485 certification, and any ownership change triggers supplemental regulatory filings. More consequential is the Hart-Scott-Rodino antitrust review, which has been running quietly since the deal announcement in late 2024. KKR has structured the transaction through a newly formed affiliate, which allows consolidation of Integer's balance sheet without triggering change-of-control provisions in certain long-term supply agreements. That structure also defers $340 million in pension liabilities by maintaining Integer as a standalone legal entity post-close.
For allocators, the signal is less about Integer's enterprise value and more about what KKR sees in the medical device supply chain. Private equity has been circling component manufacturers for two years, betting that device OEMs will continue to outsource capital-intensive production rather than invest in new facilities. Integer's customer concentration—its top five customers represent roughly 60% of revenue—makes it a leveraged bet on the device replacement cycle, particularly in cardiac rhythm management, where battery and lead component demand is growing at mid-single digits annually. KKR's track record in healthcare services suggests it will push Integer toward higher-margin contract manufacturing and away from commodity component sales.
Operators should monitor two follow-on events. First, whether KKR announces any facility rationalization within six months of closing; Integer runs plants in Texas, Mexico, and Switzerland, and consolidation would signal margin pressure exceeding current guidance. Second, watch for any customer contract renegotiations in the 90 to 120 days post-close. Device OEMs typically have exit clauses tied to ownership changes, and any public statements from Medtronic or Abbott about "supply chain reviews" would indicate pricing friction.
The Hart-Scott-Rodino review period expires in approximately 45 days unless extended, and Integer has scheduled a special meeting for final procedural votes in early April.
The takeaway
KKR's $5.7B Integer take-private is a bet on outsourced medical device manufacturing as OEMs shed capital intensity.
Editorial & Disclosure Notice: This article was written with artificial intelligence from public sources and is published without individual human review. Artificial intelligence and other digital tools are also used for research, analysis, editing, formatting, and production. Errors, omissions, outdated information, or inaccuracies may occur. References to companies, brands, products, services, organizations, or individuals are for informational and editorial purposes and do not imply endorsement, sponsorship, affiliation, partnership, or approval unless expressly stated. All trademarks and other intellectual property remain the property of their respective owners. Opinions, analysis, estimates, and commentary are informational only and should not be construed as financial, investment, legal, tax, medical, procurement, or other professional advice. Information may be corrected, clarified, or updated after publication. Corrections or removal requests: jenny@pops4.com.
Want the 60-second program for your specific event?
Enter your event and email — we build it and send the branded proposal before lunch. No obligation.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.